LifeVantage Corporation (LFVN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for LifeVantage Corporation (LFVN:NASDAQ), powered by AI.

Current Price
$4.35
Sector
Consumer Defensive
What is the LifeVantage Corporation stock price forecast?

LifeVantage Corporation is currently trading at $4.35. View real-time AI analysis on Alpha Lenz.

What is LifeVantage Corporation insider trading activity?

View the latest insider trading data for LifeVantage Corporation on Alpha Lenz.

What is LifeVantage Corporation's P/E ratio?

View LifeVantage Corporation's valuation metrics on Alpha Lenz.

LifeVantage Corporation

NASDAQ · LFVN
$4.35
Ask about LifeVantage Corporation's future dividend policy...
Alpha Chat Insight

LifeVantage Corporation's ROE is 32.3%. Explore profitability and growth together.

Ask for details

Company Overview

LifeVantage Corporation is a biotechnology company that focuses on the research and development of nutraceutical dietary supplements and skin care products. Its primary purpose is to enhance the health and well-being of individuals through science-based products that target oxidative stress, improve cellular performance, and promote healthy aging. Notable for its Protandim product line, LifeVantage operates mainly in the health and wellness industry, impacting sectors such as nutrition, personal care, and sports performance. The company distributes its products primarily through a network marketing model, which enables it to reach a wide customer base globally by leveraging independent distributors. Founded in 2003, LifeVantage is headquartered in Lehi, Utah, and holds a significant position within the network marketing and direct selling space due to its innovative approach to wellness and its commitment to scientifically-validated product offerings. The company plays a pivotal role in revolutionizing the way individuals approach health management, particularly focusing on combatting oxidative stress and enhancing longevity through nutrigenomics, a field at the intersection of nutrition, genetics, and health. This allows LifeVantage to stand out in a competitive market, driven by ever-growing consumer interest in personal health improvements.

CEOMr. Steven R. Fife CPA
SectorConsumer Defensive
IndustryPackaged Foods
Employees232

Company Statistics

FY 2025

Profile

N/AMarket Cap
$228.53MRevenue
0.00Shares Out
232Employees

Margins

80.37%Gross
6.89%EBITDA
5.34%Operating
5.36%Pre-Tax
4.29%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

3.46%Rev 3Yr
-0.38%Rev 5Yr
17.21%Op Inc 3Yr
-4.63%Op Inc 5Yr
46.48%Net Inc 3Yr
-3.22%Net Inc 5Yr

Returns

14.83%ROA
32.34%ROE
18.45%ROIC

Financial Health

$20.20MCash & Cash Equivalents
$17.12MNet Debt
107.72%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

LifeVantage Corporation (ticker: LFVN) is a company listed on NASDAQ in the Consumer Defensive sector (Packaged Foods). It has approximately 232 employees.

The current price is $4.35 with a P/E ratio of -x and P/B of -x.

ROE is 32.34% and operating margin is 5.34%. Annual revenue is $229M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
LifeVantage Corporation (Consumer Defensive) Stock Forecast & Analysis $4.35 | Alpha Lenz